Imperial College London Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University College London Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Cardiff University Featured PhD Programmes
"career"×
10 miles

Biochemistry (career) PhD Projects, Programs & Scholarships

We have 183 Biochemistry (career) PhD Projects, Programs & Scholarships

  • "career" ×
  • Biochemistry×
  • clear all
Order by 
Showing 1 to 10 of 183
  Wellcome Trust Four-Year PhD Programme in Advanced Therapies for Regenerative Medicine

Funding Type

PhD Type

The Wellcome Trust is the world's largest medical research charity, funding research into human and animal health. There are 23 new Wellcome Trust Four-Year PhD Programmes, which offer exceptional opportunities to talented researchers who wish to study for a PhD in the UK.
  Wellcome Trust Four-Year PhD Programme in Advanced Therapies for Regenerative Medicine

Funding Type

PhD Type

The Wellcome Trust is the world's largest medical research charity, funding research into human and animal health. There are 23 new Wellcome Trust Four-Year PhD Programmes, which offer exceptional opportunities to talented researchers who wish to study for a PhD in the UK.
  Wellcome Trust 4-year Doctoral Programme in Chemistry in Cells: New Technologies to Probe Complex Biology and Medicine

Funding Type

PhD Type

Explore our exceptional new DPhil course with a unique structure that's designed for you. Are you an outstanding graduate in physical/ chemical sciences considering advanced research at the interface with biomedicine?.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  MRC DiMeN Doctoral Training Partnership: Activation of Aurora Kinase A by DNA damage – understanding the signalling pathway to improve radiotherapy response
  Dr H Bryant, Prof C Eyers, Prof P Eyers
Application Deadline: 6 January 2020

Funding Type

PhD Type

Radiation is a mainstay of cancer therapy, however radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  PhD Student Positions at International Max Planck Research School for Molecular Life Sciences, Munich

Funding Type

PhD Type

The International Max Planck Research School for Molecular Life Sciences. From Biological Structures to Neural Circuits (IMPRS-LS) currently has an open call for fully funded PhD student positions.
  PhD Student Positions at International Max Planck Research School for Molecular Life Sciences, Munich

Funding Type

PhD Type

The International Max Planck Research School for Molecular Life Sciences. From Biological Structures to Neural Circuits (IMPRS-LS) currently has an open call for fully funded PhD student positions.
  MRC DiMeN Doctoral Training Partnership: Bacteriolysis: how cell envelope-targeting antibiotics trick bacteria to self-digest
  Dr H Strahl von Schulten, Dr A Fenton
Application Deadline: 6 January 2020

Funding Type

PhD Type

The bacterial cell envelope is the target for some of our most successful antibiotics including penicillins and cephalosporins, and also for last-resort antibiotics such as vancomycin and daptomycin used to treat life-threatening multidrug-resistant bacterial infections.
  MRC DiMeN Doctoral Training Partnership: Towards specialised treatments for childhood-onset neurological diseases
  Dr C Schneider, Prof R Horvath
Application Deadline: 6 January 2020

Funding Type

PhD Type

Neurodegeneration is a feature of many debilitating, incurable diseases with underlying defects in RNA metabolism (e.g. spinal muscular atrophy, ALS), but the link between RNA biology and neuronal death is poorly understood.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.